128 results
Read about new open access clinical care content in EBSCO’s COVID-19 Information Portal from Jessica Bartell, MD, MS, Chief Medical Officer, Clinical Decision Support, EBSCO Clinical Decisions.
A new project from EBSCO is helping clinicians bridge the evidence gap between trial data reporting and publication of peer-reviewed articles during the COVID-19 pandemic.
Read about the development of a COVID-19 information portal from Brian S. Alper, MD, MSPH, FAAFP, FAMIA.
With the start of the school year around the corner, risk of COVID-19 is a top concern for parents, teachers, school administrators and pediatricians. Here’s a roundup of what we know about COVID-19 vaccines for children and adolescents.
The page views are in! The team at DynaMed® has compiled your favorite medical blogs from EBSCO Health Notes in 2020.
Ivermectin is an antiparasitic agent with in vitro activity against SARS-CoV-2 but as-of-yet unclear efficacy for treatment of COVID-19. The latest EBM Focus article discusses another trial.
COVID-19 is associated with coagulopathy and risk for thrombotic complications, but not all patients should get anticoagulation. Here is a new tool from the DynaMed Decisions® team at EBSCO that takes the guess work out of this clinical decision.
Vaccination remains the most effective method to prevent severe outcomes of COVID-19, but what do we know about medications for pre-exposure and postexposure prophylaxis?
Two categories of COVID-19-directed therapy are now available to high-risk outpatients with COVID-19: monoclonal antibody therapy and antiviral agents. Hear from DynaMed® editors about outpatient therapy.
In this unique EBM Focus article, the DynaMed team answers ten frequently asked questions about coronavirus disease 2019 (COVID-19).